Author(s):
Shadan Muslim Aljanabi, Shaza Al-Laham, Adnan M. Ekhtiar
Email(s):
shadan.m.aljanabi@gmail.com
DOI:
Not Available
Address:
Shadan Muslim Aljanabi1*, Shaza Al-Laham1, Adnan M. Ekhtiar2
1Pharmacology Department, Collage of Pharmacy, Damascus University, Syria
2Biotechnology Department, Syrian Atomic Energy Commission, Syria
*Corresponding Author
Published In:
Volume - 6,
Issue - 6,
Year - 2013
ABSTRACT:
Our preliminary data indicate that Oxytocin may be myeloprotective. We investigated whether it can modify bone marrow recovery. Oxytocin (150 µg/kg) accelerated the recovery of the number of medium size cells (MI%) and platelets (PLT) but did not affect the number of circulating red blood cells (RBC) and total count of white blood cells (WBC).Oxytocin injected subcutaneously for 5 consecutive days at doses of 150 µg/kg (twice a day) after 5-FU single dose. Glutathione GSH (anti-oxidant) has preventive effects against 5-FU-induced myelosuppression and can accelerate recovery of bone marrow. Oxytocin only increase GSH levels insignificantly (P > 0.05).These findings suggest that Oxytocinselectively enhances the recovery of the population of progenitor cells reduced by 5-FU in rats.
Cite this article:
Shadan Muslim Aljanabi, Shaza Al-Laham, Adnan M. Ekhtiar. Accelerated Recovery of 5-Fluorouracil-Damaged Bone Marrow after Oxytocin Treatment. Research J. Pharm. and Tech 6(6): June 2013; Page 685-687.
Cite(Electronic):
Shadan Muslim Aljanabi, Shaza Al-Laham, Adnan M. Ekhtiar. Accelerated Recovery of 5-Fluorouracil-Damaged Bone Marrow after Oxytocin Treatment. Research J. Pharm. and Tech 6(6): June 2013; Page 685-687. Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2013-6-6-10